Prescription Assistance Resources
Plain-English guides on patient assistance programs, medication costs, and how to get the help you deserve.
Compounded Ozempic Is About to Disappear — What That Means for You
The FDA is banning compounded semaglutide and tirzepatide by June 30, 2026. If you've been using a compounding pharmacy for your GLP-1, here's what to expect and what your options are.
More Articles
Real-World Results: What Actually Happens When Patients Switch to Humira Biosimilars
Clinical trials proved biosimilars are equivalent to Humira in controlled settings. Real-world data from 2025-2026 shows how those results hold up — and what predicts who has a smooth transition versus who struggles.
Eliquis vs. Warfarin: Why Patients Switch — and Why Cost Becomes the Problem
Millions of patients switched from warfarin to Eliquis for good clinical reasons. But the cost difference is dramatic. Here's what to know and what to do if you can't afford Eliquis.
Medicaid and Humira: Why Coverage Depends on Where You Live
Medicaid coverage for Humira and adalimumab biosimilars varies significantly by state — and often requires step therapy or extensive prior authorization. Here's a practical guide for Medicaid patients, including how to appeal denials.
Eliquis and the Medicare Part D Changes in 2025: What Patients Need to Know
The biggest change to Medicare Part D drug coverage in years took effect in 2025. Here's what changed, how it affects Eliquis costs, and what Medicare beneficiaries should do now.
Why Your Humira Costs May Vary by $2,000 Depending on Where You Work
The same adalimumab biosimilar costs $639 at one employer and $2,655 at another. Self-funded employer plans set their own drug benefit terms — and most employees have no idea. Here's how to find out what your plan is actually paying.
How to Get Eliquis for Free or Reduced Cost: A Complete Guide
Eliquis can cost $600 or more per month without help. Here's every legitimate way to reduce or eliminate your out-of-pocket cost — from manufacturer assistance programs to Medicare options.
How to Afford Eliquis If You're Uninsured
No insurance doesn't mean no options. Several programs can help uninsured patients get Eliquis at little or no cost. Here's what's available and how to access it.
Prescription Assistance Guide for Uninsured Patients
Uninsured and struggling to afford medications? Learn how prescription assistance programs work, who qualifies, and how ClariMeds can help you get started.
How to Appeal a Humira or Adalimumab Biosimilar Insurance Denial
Getting denied for Humira or a biosimilar doesn't mean the answer is final. Here's a step-by-step guide to filing an appeal — including what documentation to get, what deadlines to watch, and what external review rights you have.
How to Get Ozempic for $349/Month (Without Insurance)
Novo Nordisk cut Ozempic's self-pay price in 2026. Here's exactly how to access the new $349/month rate, which savings programs to stack, and what to do if you still can't afford it.
What Happens If You Can't Afford to Stay on Eliquis? The Real Risks
Stopping Eliquis because of cost is more common than doctors know — and more dangerous than many patients realize. Here's what the risks are and what to do before you stop taking it.
Your Doctor Says Don't Switch. Your Insurance Says You Have To. Who Wins?
Rheumatology guidelines recommend against mandatory biosimilar switching for stable patients. Here's how to use that clinical guidance — and your legal rights — to push back against a formulary-driven switch you don't want.
Manufacturer Coupon vs. GoodRx vs. Patient Assistance: Which Saves You the Most on GLP-1s?
Three programs can reduce GLP-1 costs — but they work very differently and can't always be combined. Here's exactly which one to try first based on your insurance situation.
The PBM Formulary Game Nobody Explains to Patients
CVS Caremark, Optum Rx, and Express Scripts each created private-label biosimilars and rewrote their Humira formularies around them. Patients are being routed to specific drugs for financial reasons — not clinical ones. Here's how to see through it.
The BMS Access Support Program: Who Qualifies and How to Apply
Bristol-Myers Squibb's free medication program can cover 100% of the cost of Eliquis for qualifying patients. Here's exactly who qualifies and how the application process works.
How Medicare Patients Can Get Adalimumab for Under $2,100/Year in 2026
Medicare Part D's new $2,100 annual out-of-pocket cap changes the math for seniors on adalimumab. Here's how to combine the cap with biosimilar pricing and Extra Help to reach the lowest possible cost.
How to Help a Loved One Afford Prescriptions in 2026
Learn how to help a loved one access free brand name medication, Medicare Extra Help, and prescription assistance programs that fit their situation.
Humira Complete vs. Biosimilar PAPs: Which Copay Program Saves You More?
AbbVie's $5/month Humira Complete card and biosimilar manufacturer PAPs work very differently. Here's exactly which program applies to your situation — and which one gets you to the lowest cost.
Eliquis on Medicare: What Part D Covers and How to Cut Your Costs
Medicare covers Eliquis through Part D, but out-of-pocket costs can still be significant. Here's how the coverage works, what changed in 2025, and how to pay as little as possible.
Can You Get a Generic Eliquis? What to Know About Generic Apixaban
Generic versions of Eliquis (apixaban) are now available in the U.S. Here's what they cost, where to find them, and whether they're the right choice for your situation.
Is It Safe to Switch from Humira to a Biosimilar? What the 2026 Data Says
1 in 8 patients who switch to adalimumab biosimilars return to Humira within 30 days — but most do so without any clinical reason. Here's what the research actually says about biosimilar switching safety.
Your Insurance Switched You to a Humira Biosimilar Without Warning. Now What?
PBMs are removing brand Humira from formularies and substituting biosimilars — often mid-year, often without clear notice to patients. Here's what's safe, what's not, and how to push back if you're a stable patient.
How ClariMeds Helps Eliquis Patients Get Approved for Assistance
Navigating Eliquis assistance programs is complicated — paperwork, doctor coordination, eligibility rules. ClariMeds handles it for you. Here's how the process works.
What Is Eliquis Used For? AFib, DVT, and Blood Clot Prevention Explained
Eliquis is prescribed for several serious conditions involving blood clots. Here's what each condition means, why Eliquis is used, and what patients should know about taking it long-term.
10 FDA-Approved Humira Biosimilars: What's the Difference and Which Has the Best Assistance Program?
Ten FDA-approved adalimumab biosimilars are now on the market. Here's a plain-language guide to what makes them different, what "interchangeable" actually means, and which ones offer the strongest patient assistance.
Rx Junk Fees: Hidden Drug Costs & How to Fight Back
Learn how spread pricing and PBM fees inflate your prescriptions—and how patient assistance programs and new 2026 reforms can cut your costs.
The Surprising Reason Humira Now Costs More Than Some of Its Biosimilars
Something counterintuitive happened in the adalimumab market: brand Humira's net price dropped below some biosimilars' prices. Here's why — and what it means if you're trying to figure out which version to get.
Eliquis Coupon Cards: What Works, What Doesn't, and Better Alternatives
Eliquis copay cards and coupons can help some patients — but they're completely off-limits for Medicare beneficiaries. Here's what actually works depending on your insurance status.
AbbVie Is Closing Its Free Humira Program — Here's What to Do Before July 1
myAbbVie Assist stops accepting new Humira applications on July 1, 2026. Here's a step-by-step guide for current patients and those who were about to apply — including which biosimilar assistance programs to use instead.
Employer GLP-1 Coverage Dropped? Your 2026 Options Explained
Lost employer coverage for Ozempic or Wegovy? Learn why it's happening and how prescription assistance programs can help you stay on your medication.
Medicare 2026: Why the Part D Cap Is Now $2,100
The Medicare Part D out-of-pocket cap rises to $2,100 in 2026. Learn what's driving the change and how prescription assistance programs can help.
350 Brand-Name Drugs Getting Pricier in 2026: What Patients Should Know
Over 350 brand-name drugs face 2026 price hikes. Learn which medications are affected and how a prescription assistance program can help you save.
State Drug Price Transparency Laws: 2026 Update
See what's changed in 2026 state drug transparency laws—price hike disclosures, PBM rebates, and how ClariMeds helps with prescription assistance.
How to Talk to Your Doctor About Drug Costs
Struggling to afford medication? Learn essential steps to talk to your doctor about drug costs, including our top tips.
2026 Formulary Changes: Is Your Medication Still Covered?
Formularies are shifting in 2026. Learn how to check your coverage, request exceptions, and find prescription assistance if your medication costs spike.
2026's Worst Drug Shortages & Where Patients Can Get Help
Drug shortages in 2026 are putting patients at risk. Discover which medications are affected and how a patient assistance program can help.
How Age & State Affect Health Care Costs + How to Get Help
See how your age and location drive up health care costs, and learn how ClariMeds connects uninsured patients with free brand-name medication assistance programs.
Why Americans Pay More for Prescriptions — And What's Changing
Americans pay far more for brand-name drugs than other countries. Learn why prices are so high and how prescription assistance programs can help.
Top 10 Trends Driving US Health Care Spending Today
From rising drug costs to aging patients, explore the 10 biggest trends shaping US health care spending—and how prescription assistance programs can help.
FDA Halts Off-Brand Ozempic: What Patients Need to Know
The FDA ended the Ozempic shortage, stopping compounded semaglutide sales. Learn what this means and how a prescription assistance program can help.
New FDA Rules May Raise Drug Prices & Slow Medication Access
New FDA regulatory changes could drive up drug costs and delay access. Learn how a prescription assistance program can help you stay covered.